Literature DB >> 30304410

Methicillin-resistant Staphylococcus aureus Nasal Screening Adds Limited Value to the Choice of Empiric Antibiotics in Community-acquired Pneumonia.

Jason P Burnham1, Monika K Kakol2, M Cristina Vazquez Guillamet2,3.   

Abstract

Entities:  

Year:  2019        PMID： 30304410      PMCID： PMC6769396          DOI： 10.1093/cid/ciy868

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study.

Authors:  Stefano Aliberti; Luis F Reyes; Paola Faverio; Giovanni Sotgiu; Simone Dore; Alejandro H Rodriguez; Nilam J Soni; Marcos I Restrepo
Journal:  Lancet Infect Dis       Date:  2016-09-01       Impact factor: 25.071

2.  The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications.

Authors:  Diane M Parente; Cheston B Cunha; Eleftherios Mylonakis; Tristan T Timbrook
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

3.  Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.

Authors:  Wesley H Self; Richard G Wunderink; Derek J Williams; Yuwei Zhu; Evan J Anderson; Robert A Balk; Sherene S Fakhran; James D Chappell; Geoffrey Casimir; D Mark Courtney; Christopher Trabue; Grant W Waterer; Anna Bramley; Shelley Magill; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.